PAPER Engelborghs S, Maertens K, Mariën P, Vloeberghs E, Somers N, Nagels G, De Deyn PP

Behavioural and neuropsychological correlates of frontal lobe features in dementia.

Psychol Med. 2006 Aug;36(8):1173-82. PubMed: 16700962

PAPER Moser KV, Stöckl P, Humpel C

Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: counteraction by NGF, MK-801 and inflammation.

Exp Gerontol. 2006 Jun;41(6):609-18. PubMed: 16701975

PAPER Lambert JC, Bensemain F, Chapuis J, Cottel D, Amouyel P

Association study of the PIN1 gene with Alzheimer's disease.

Neurosci Lett. 2006 Jul 24;402(3):259-61. PubMed: 16701948

PAPER Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T

PINK1 protein in normal human brain and Parkinson's disease.

Brain. 2006 Jul;129(Pt 7):1720-31. PubMed: 16702191

PAPER Selhub J

The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.

J Nutr. 2006 Jun;136(6 Suppl):1726S-1730S. PubMed: 16702347

PAPER Cotelli M, Calabria M, Zanetti O

Cognitive rehabilitation in Alzheimer's Disease.

Aging Clin Exp Res. 2006 Apr;18(2):141-3. PubMed: 16702783

PAPER Panza F, Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Palasciano R, Todarello O, Capurso S, Pellicani V, Capurso A

Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.

Aging Clin Exp Res. 2006 Apr;18(2):144-8. PubMed: 16702784

PAPER Lio D, Scola L, Romano GC, Candore G, Caruso C

Immunological and immunogenetic markers in sporadic Alzheimer's disease.

Aging Clin Exp Res. 2006 Apr;18(2):163-6. PubMed: 16702788

PAPER Fernández-Turrado T, Tejero-Juste C, Santos-Lasaosa S, Pérez-Lázaro C, Piñol-Ripoll G, Mostacero-Miguel E, Pascual-Millán LF

[Language and cognitive impairment: a semiological study into visual naming].

Rev Neurol. 2006 May 16-31;42(10):578-83. PubMed: 16703524

PAPER Tanović A, Alfaro V

[Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].

Rev Neurol. 2006 May 16-31;42(10):607-16. PubMed: 16703529

PAPER Negash S, Petersen LE, Geda YE, Knopman DS, Boeve BF, Smith GE, Ivnik RJ, Howard DV, Howard JH, Petersen RC

Effects of ApoE genotype and mild cognitive impairment on implicit learning.

Neurobiol Aging. 2007 Jun;28(6):885-93. PubMed: 16701920

PAPER Racchi M, Porrello E, Lanni C, Lenzken SC, Mazzucchelli M, Govoni S

Role of acetylcholinesterase inhibitors in pharmacological regulation of amyloid precursor protein processing.

Aging Clin Exp Res. 2006 Apr;18(2):149-52. PubMed: 16702785

PAPER Bianchetti A, Ranieri P, Margiotta A, Trabucchi M

Pharmacological treatment of Alzheimer's Disease.

Aging Clin Exp Res. 2006 Apr;18(2):158-62. PubMed: 16702787

PAPER He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB, Hong Z

The Fas gene A-670G polymorphism is not associated with sporadic Alzheimer disease in a Chinese Han population.

Brain Res. 2006 Apr 12;1082(1):192-5. PubMed: 16703675

AChE (AR-1)

ANTIBODY monoclonal AR-1 manufacturer Cat# MAB337 immunogen = acetylcholinesterase AChE from human erythrocyte liquid, ascites, PBS, glycerol, HEPES, Tris-HCl, BSA, PVP-40, Tween 20, azide acetylcholinesterase not WB IgG₁ Acetylcholine Recep